We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Defenx Plc | LSE:DFX | London | Ordinary Share | GB00BYNF4J61 | ORD GBP0.018 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.60 | 0.50 | 2.70 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDFX
RNS Number : 4928V
Defenx plc
09 April 2019
9 April 2019
Defenx PLC
("Defenx", the "Company" or the "Group")
BV Tech Distribution Agreement and Software Services Agreement
Related Party Transactions
Defenx PLC (AIM: DFX), the cyber-security software group, is pleased to announce that it has entered into a software distribution agreement and a software services agreement with BV Tech S.p.A. ("BV Tech"), the Company's majority shareholder.
Distribution Agreement
The Company's wholly owned subsidiary Defenx Italia Srl ("Defenx Italia") has entered into a software distribution agreement with BV Tech (the "Distribution Agreement"), which amends the previous software distribution agreement entered into with BV Tech, as originally announced on 22 June 2017 (the "2017 Distribution Agreement").
Pursuant to the Distribution Agreement, BV Tech:
i) will have the sole rights to sell Defenx products to certain bodies within the Italian defence, space, national security or critical infrastructures sectors, through to the end of December 2023 for which BV Tech will pay Defenx a total consideration of EUR1.0 million, to be invoiced in three instalments before the end of H1 2019. In addition, Defenx will receive a royalty fee equal to 50% of any revenues from the sale of its products (during the period to 31 December 2023) to such clients in excess of EUR5.0 million; and
ii) has committed to purchase Defenx's products, with a minimal value of EUR1.2 million, over a two year period, effective from 1 January 2019. Accordingly, Defenx will receive a minimum of EUR1.2 million in a number of instalments over the two year period from BV Tech for such products. The previous restrictions regarding the distribution of Defenx's products have also been removed, such that BV Tech is now able to distribute, on a non-exclusive basis, all of Defenx's products, other than those covered by i) above, through any direct and indirect channel of distribution or sales through to 31 December 2021.
The value of any Defenx products sold by BV Tech pursuant to the Distribution Agreement will, unless agreed otherwise by the parties, be based on the prices set out in the 2017 Distribution Agreement.
All other terms of the previous 2017 Distribution Agreement remain the same.
Services Agreement
Defenx, via Defenx Italia, has also entered into a software services agreement with BV Tech (the "Services Agreement"), pursuant to which BV Tech will undertake to provide services to Defenx in respect of its range of new and existing products over the course of 2019. The aggregate fee payable by the Company to BV Tech for the services under the Services Agreement is calculated and payable monthly on a 'time spent' basis, capped at EUR1.2 million.
The Services Agreement contains warranties in favour of Defenx Italia in respect of the intellectual property created pursuant to the services. BV Tech has the right of first refusal to extend the Services Agreement for a further year on the same terms, subject to its fees and/or timing for delivery of its services at least matching terms proposed by third party suppliers, all other criteria being at least equal. The Services Agreement contains a number of termination rights of each party, for cause, rather than for convenience.
The Services Agreement does not form part of the master services agreement previously entered into with BV Tech, as announced on 27 September 2017.
Following entering into the Service Agreement, Defenx will focus on completing work on its product portfolio and now expects to be in a position to launch new products in Q2 2019.
Related Party Transactions
As BV Tech is a substantial shareholder of the Company as defined in the AIM Rules for Companies ("AIM Rules"), the Distribution Agreement and the Services Agreement (together the "Agreements") are classified as related party transactions pursuant to AIM Rule 13. Accordingly, the independent Directors of the Company (being all the Directors other than Raffaele Boccardo who is a director of and interested in BV Tech), having consulted with the Company's Nominated Adviser, Strand Hanson Limited, consider that the terms of the Agreements are fair and reasonable insofar as the Company's shareholders are concerned.
Enquiries
Defenx PLC Anthony Reeves - Executive Chairman 020 3198 9414 IFC Advisory (Financial PR and IR) Tim Metcalfe / Graham Herring / Heather Armstrong 020 3934 6630 Strand Hanson Limited (Nominated and Financial Adviser) Richard Tulloch / Stuart Faulkner / James Bellman 020 7409 3494 WH Ireland (Broker) Adrian Hadden 020 7220 1666
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCIPMATMBAMBPL
(END) Dow Jones Newswires
April 09, 2019 02:00 ET (06:00 GMT)
1 Year Defenx Chart |
1 Month Defenx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions